English
简体中文
Total: £ 56.28
Published Date: 2025-09-15 | Pages: 93 | Tables: 98 | Medical Devices & Consumables
The global market for Neuromodulation Devices and Implantable Infusion Pumps was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson"s disease, Epilepsy, etc.
This report aims to provide a comprehensive presentation of the global market for Neuromodulation Devices and Implantable Infusion Pumps, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Neuromodulation Devices and Implantable Infusion Pumps by region & country, by Type, and by Application.
The Neuromodulation Devices and Implantable Infusion Pumps market size, estimations, and forecasts are provided in terms of sales volume (Unit) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation Devices and Implantable Infusion Pumps.
Market Segmentation
By Company
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Neuromodulation Devices and Implantable Infusion Pumps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Neuromodulation Devices and Implantable Infusion Pumps in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Neuromodulation Devices and Implantable Infusion Pumps Product Introduction
1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2020-2031)
1.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume (2020-2031)
1.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Price (2020-2031)
1.3 Neuromodulation Devices and Implantable Infusion Pumps Market Trends & Drivers
1.3.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
1.3.2 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers & Opportunity
1.3.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
1.3.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Players Revenue Ranking (2024)
2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025)
2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Players Sales Volume Ranking (2024)
2.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Company Players (2020-2025)
2.5 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Company (2020-2025)
2.6 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base and Headquarters
2.7 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Neuromodulation Devices and Implantable Infusion Pumps
2.9 Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Analysis
2.9.1 Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Neuromodulation Devices and Implantable Infusion Pumps Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Spinal Cord Stimulation
3.1.2 Deep Brain Stimulation
3.1.3 Sacral Nerve Stimulation
3.1.4 Vagal Nerve Stimulation
3.1.5 Gastric Stimulation
3.1.6 Transcranial Magnetic Stimulation
3.1.7 Transcutaneous Electrical Stimulation
3.1.8 Other
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value, by Type (2020-2031)
3.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value, by Type (%) (2020-2031)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type
3.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume, by Type (2020-2031)
3.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume, by Type (%) (2020-2031)
3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Parkinson's Disease
4.1.2 Epilepsy
4.1.3 Pain
4.1.4 Other
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value, by Application (2020-2031)
4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value, by Application (%) (2020-2031)
4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application
4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume, by Application (2020-2031)
4.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume, by Application (%) (2020-2031)
4.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region
5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2020-2025)
5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2026-2031)
5.1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (%), (2020-2031)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region
5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region (2020-2025)
5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region (2026-2031)
5.2.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region (%), (2020-2031)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
5.4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
5.5.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
5.6.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
5.7.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
5.8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Value
6.2.1 Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
6.2.2 Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
6.3.2 United States Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
6.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
6.5.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
6.5.3 China Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
6.6.2 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
6.7.2 South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
6.8.2 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020-2031
6.9.2 India Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
6.9.3 India Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.1.5 Medtronic Recent Development
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Company Information
7.2.2 Boston Scientific Corporation Introduction and Business Overview
7.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.2.5 Boston Scientific Corporation Recent Development
7.3 St. Jude Medical
7.3.1 St. Jude Medical Company Information
7.3.2 St. Jude Medical Introduction and Business Overview
7.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.3.5 St. Jude Medical Recent Development
7.4 Synapse Biomedical
7.4.1 Synapse Biomedical Company Information
7.4.2 Synapse Biomedical Introduction and Business Overview
7.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.4.5 Synapse Biomedical Recent Development
7.5 Nevro Corporation
7.5.1 Nevro Corporation Company Information
7.5.2 Nevro Corporation Introduction and Business Overview
7.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.5.5 Nevro Corporation Recent Development
7.6 Neuropace
7.6.1 Neuropace Company Information
7.6.2 Neuropace Introduction and Business Overview
7.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.6.5 Neuropace Recent Development
7.7 Cyberonics
7.7.1 Cyberonics Company Information
7.7.2 Cyberonics Introduction and Business Overview
7.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.7.5 Cyberonics Recent Development
7.8 Autonomic Technologies
7.8.1 Autonomic Technologies Company Information
7.8.2 Autonomic Technologies Introduction and Business Overview
7.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.8.5 Autonomic Technologies Recent Development
7.9 Avery Biomedical
7.9.1 Avery Biomedical Company Information
7.9.2 Avery Biomedical Introduction and Business Overview
7.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.9.5 Avery Biomedical Recent Development
7.10 Greatbatch Medical
7.10.1 Greatbatch Medical Company Information
7.10.2 Greatbatch Medical Introduction and Business Overview
7.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
7.10.5 Greatbatch Medical Recent Development
8 Industry Chain Analysis
8.1 Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain
8.2 Neuromodulation Devices and Implantable Infusion Pumps Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Model
8.5.2 Sales Channel
8.5.3 Neuromodulation Devices and Implantable Infusion Pumps Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Neuromodulation Devices and Implantable Infusion Pumps Market Trends
Table 2. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers & Opportunity
Table 3. Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
Table 4. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2020-2025)
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Company (2020-2025) & (Unit)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Neuromodulation Devices and Implantable Infusion Pumps Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base and Headquarters
Table 11. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Neuromodulation Devices and Implantable Infusion Pumps
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type (2020-2025)
Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type (2026-2031)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type: 2020 VS 2024 VS 2031 (Unit)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2020-2025) & (Unit)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2026-2031) & (Unit)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application (2020-2025)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application (2026-2031)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application: 2020 VS 2024 VS 2031 (Unit)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2020-2025) & (Unit)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2026-2031) & (Unit)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2020-2025) & (USD/Unit)
Table 39. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2026-2031) & (USD/Unit)
Table 40. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2020-2025) & (%)
Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2026-2031) & (%)
Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region (Unit): 2020 VS 2024 VS 2031
Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region (2020-2025) & (Unit)
Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region (2026-2031) & (Unit)
Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region (2020-2025) & (%)
Table 49. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Region (2026-2031) & (%)
Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Volume, (2020-2025) & (Unit)
Table 56. Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Volume, (2026-2031) & (Unit)
Table 57. Medtronic Company Information
Table 58. Medtronic Introduction and Business Overview
Table 59. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 61. Medtronic Recent Development
Table 62. Boston Scientific Corporation Company Information
Table 63. Boston Scientific Corporation Introduction and Business Overview
Table 64. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 66. Boston Scientific Corporation Recent Development
Table 67. St. Jude Medical Company Information
Table 68. St. Jude Medical Introduction and Business Overview
Table 69. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 71. St. Jude Medical Recent Development
Table 72. Synapse Biomedical Company Information
Table 73. Synapse Biomedical Introduction and Business Overview
Table 74. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 76. Synapse Biomedical Recent Development
Table 77. Nevro Corporation Company Information
Table 78. Nevro Corporation Introduction and Business Overview
Table 79. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 81. Nevro Corporation Recent Development
Table 82. Neuropace Company Information
Table 83. Neuropace Introduction and Business Overview
Table 84. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 86. Neuropace Recent Development
Table 87. Cyberonics Company Information
Table 88. Cyberonics Introduction and Business Overview
Table 89. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 91. Cyberonics Recent Development
Table 92. Autonomic Technologies Company Information
Table 93. Autonomic Technologies Introduction and Business Overview
Table 94. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 96. Autonomic Technologies Recent Development
Table 97. Avery Biomedical Company Information
Table 98. Avery Biomedical Introduction and Business Overview
Table 99. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 101. Avery Biomedical Recent Development
Table 102. Greatbatch Medical Company Information
Table 103. Greatbatch Medical Introduction and Business Overview
Table 104. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Offerings
Table 106. Greatbatch Medical Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Neuromodulation Devices and Implantable Infusion Pumps Downstream Customers
Table 110. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Product Picture
Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume (2020-2031) & (Unit)
Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Price (2020-2031) & (USD/Unit)
Figure 6. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 7. Global Neuromodulation Devices and Implantable Infusion Pumps Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Neuromodulation Devices and Implantable Infusion Pumps Players Sales Volume Ranking (2024) & (Unit)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Neuromodulation Devices and Implantable Infusion Pumps Revenue in 2024
Figure 10. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Spinal Cord Stimulation Picture
Figure 12. Deep Brain Stimulation Picture
Figure 13. Sacral Nerve Stimulation Picture
Figure 14. Vagal Nerve Stimulation Picture
Figure 15. Gastric Stimulation Picture
Figure 16. Transcranial Magnetic Stimulation Picture
Figure 17. Transcutaneous Electrical Stimulation Picture
Figure 18. Other Picture
Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Market Share by Type, 2024 & 2031
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2020 VS 2024 VS 2031) & (Unit)
Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Market Share by Type, 2024 & 2031
Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2020-2031) & (USD/Unit)
Figure 24. Product Picture of Parkinson's Disease
Figure 25. Product Picture of Epilepsy
Figure 26. Product Picture of Pain
Figure 27. Product Picture of Other
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Market Share by Application, 2024 & 2031
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2020 VS 2024 VS 2031) & (Unit)
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Market Share by Application, 2024 & 2031
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2020-2031) & (USD/Unit)
Figure 33. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2020-2031) & (US$ Million)
Figure 34. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (%), 2024 VS 2031
Figure 35. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 36. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (%), 2024 VS 2031
Figure 37. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (%), 2024 VS 2031
Figure 39. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 40. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (%), 2024 VS 2031
Figure 41. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (%), 2024 VS 2031
Figure 43. Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Value (%), (2020-2031)
Figure 44. Key Countries/Regions Neuromodulation Devices and Implantable Infusion Pumps Sales Volume (%), (2020-2031)
Figure 45. United States Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 46. United States Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
Figure 47. United States Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (%), 2024 VS 2031
Figure 48. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 49. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
Figure 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (%), 2024 VS 2031
Figure 51. China Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 52. China Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
Figure 53. China Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (%), 2024 VS 2031
Figure 54. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 55. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
Figure 56. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (%), 2024 VS 2031
Figure 57. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 58. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
Figure 59. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (%), 2024 VS 2031
Figure 60. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 61. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
Figure 62. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (%), 2024 VS 2031
Figure 63. India Neuromodulation Devices and Implantable Infusion Pumps Sales Value, (2020-2031) & (US$ Million)
Figure 64. India Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (%), 2024 VS 2031
Figure 65. India Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (%), 2024 VS 2031
Figure 66. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain
Figure 67. Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Cost Structure
Figure 68. Channels of Distribution (Direct Sales, and Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
